The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Organogenesis posts 6% sequential Q3 revenue growth as 2026 loss widens

Nov 7, 2026 15:09 (1d ago)

Verifying

Organogenesis reported 6% sequential third-quarter revenue growth despite a 70% annual net product revenue decline.
$45.5 million represented third-quarter net product revenue, while gross margin fell to 52%.
Organogenesis expects Norwood remediation to finish by September 30, 2027.